Muscle Protein Synthesis Regulation
Skeletal muscle protein turnover is the net of muscle protein synthesis (MPS) and breakdown (MPB): positive net protein balance (NPB = MPS − MPB > 0) is required for muscle hypertrophy. MPS is regulated by: (1) amino acid availability — particularly leucine, which is the primary mTORC1 activator via Sestrin2–GATOR2–Rag GTPase sensing; (2) hormonal signals — insulin (PI3K→Akt) and IGF-1 (PI3K→Akt→mTORC1) inhibit MPB via FOXO phosphorylation and activate mTORC1; (3) mechanical load — FAK→PLD→phosphatidic acid activates mTORC1 independent of amino acid sensing. In sarcopenia, ageing muscle shows ‘anabolic resistance’: blunted mTORC1 response to amino acids and exercise, requiring higher leucine doses (~3–4g vs. 1.5–2g in young) to achieve equivalent MPS stimulation.
Spirulina Mechanisms in Protein Synthesis
Complete Essential Amino Acid Profile and Bioavailability
Spirulina (65% protein by dry weight) provides all 9 essential amino acids with a DIAAS (digestible indispensable amino acid score) of ~0.75–0.85 (vs. whey 1.09; soy 0.91), limited by methionine content. A 10g serving provides: leucine ~0.7g, isoleucine ~0.4g, valine ~0.4g, lysine ~0.45g, threonine ~0.35g, tryptophan ~0.12g, methionine ~0.15g, phenylalanine ~0.35g, histidine ~0.15g. While not replacing high-quality animal protein for maximal MPS, spirulina amino acid provision contributes to reaching the leucine threshold (~2–3g/meal) when combined with dietary protein. In low-protein diet supplementation studies, spirulina raises 24h amino acid availability and reduces the meal frequency required for positive NPB.
mTORC1–S6K1 Leucine Sensing Activation
Leucine from spirulina protein digestion reaches skeletal muscle interstitium, where leucine-sensing Sestrin2 releases GATOR1 inhibition of Rag GTPase, enabling mTORC1 translocation to lysosomal surface for Rheb-GTPase activation. Active mTORC1 phosphorylates S6K1 (Thr389) and 4EBP1 (Thr37/46), increasing ribosomal biogenesis (S6K1→rpS6) and eIF4E-cap-dependent translation initiation (4EBP1 release). In exercised rodent models, spirulina supplementation increases muscle mTOR phosphorylation +20–30% vs. unsupplemented controls at equivalent protein intake, suggesting additional AMPK→mTOR signalling contribution beyond leucine sensing alone.
IGF-1 Upregulation via Amino Acid–AMPK–FOXO Axis
Adequate amino acid availability (particularly BCAA) reduces AMPK activity in myocytes at rest, allowing mTOR-AKT to phosphorylate FOXO1/3 (nuclear exclusion), derepressing IGF-1 autocrine production (+15–25% muscle IGF-1 mRNA). Spirulina zinc (~1.2–1.8 mg/10g) supports GH receptor signalling (zinc required for GHR dimerisation and JAK2 activation), amplifying IGF-1 production at the somatotropic axis level. Increased local IGF-1 activates PI3K→Akt→mTORC1 and suppresses MAFbx/MuRF1 ubiquitin ligases (−20–30% MPB markers), improving net protein balance.
Nitrogen Retention and Net Protein Balance
Spirulina supplementation in resistance-trained subjects increases 72h nitrogen retention by 8–15% (24h urinary nitrogen reduction indicating lower protein oxidation relative to intake), consistent with improved protein utilisation efficiency. Post-exercise MPS rate measured by stable isotope techniques (13C-phenylalanine incorporation) increases +15–25% at 2–4 hours post-exercise with spirulina vs. placebo at matched protein intakes, suggesting mTOR sensitisation beyond amino acid delivery alone. This MPS augmentation correlates with 4–8 week lean mass gains of 0.5–1.0 kg greater than placebo in resistance training studies.
Clinical Outcomes in Muscle Protein Synthesis
- Lean mass gain (12-week resistance training): +0.5–1.0 kg vs. placebo
- Post-exercise MPS rate: +15–25%
- Serum IGF-1: +15–25%
- Urinary nitrogen retention: +8–15%
- DOMS (muscle damage markers): −20–30% (antioxidant-mediated)
- Grip strength (sarcopenia models): +10–20%
Dosing and Drug Interactions
Muscle hypertrophy support: 5–10g daily; peri-workout timing (within 2h of exercise). Leucine supplementation: Additive; spirulina +2g leucine reaches optimal mTORC1 threshold. Creatine: Mechanistically orthogonal; popular combined stack. mTOR inhibitors (rapamycin/everolimus): Spirulina mTOR activation mechanistically antagonised by rapamycin; avoid in transplant immunosuppression context. Corticosteroids (catabolic): Spirulina IGF-1/mTOR support partially offsets corticosteroid-driven MPB. Summary: EAA provision with leucine mTORC1 activation, MPS +15–25%, IGF-1 +15–25%, nitrogen retention +8–15%; dosing 5–10g peri-exercise. NK concern: low.